ORBIMED ADVISORS LLC - Director at Sionna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Issuer Symbol
SION on Nasdaq
All Insider Reports
All Insider Reports

ORBIMED ADVISORS LLC - trading volume in the past year for Sionna Therapeutics, Inc.

Holdings reported by ORBIMED ADVISORS LLC for Sionna Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,530,702 $157,398,695 $44.58 03 Feb 2026 Indirect
Series B convertible preferred stock 0 10 Feb 2025 Indirect Common Stock
Series C convertible preferred stock 0 10 Feb 2025 Indirect Common Stock

Transactions reported by ORBIMED ADVISORS LLC for Sionna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.